Skip to main content

Table 2 Summarized overview of the 5'UTR variants that were prioritized as candidates

From: Combining a prioritization strategy and functional studies nominates 5’UTR variants underlying inherited retinal disease

ID

Cohort

Retinal phenotype

Inheritance pattern

Gene

GRCh38 coordinates

Variant

Zygosity

MAF

5'UTR variant interpretation

Segregation

Captured by WESb

Reference

F1a

GE

Macular dystrophy

Sporadic (AR)

RDH12

chr14:67722520C>T

NM_152443.3: c.-123C>T

Heterozygous

0.00008544

uAUG gain: uORF with a stop codon in 5’UTR

Yes

No

Thompson et al., 2005 [96]

chr14:67729233G>A

NM_152443.3: c.701G>A (p.Arg234His)

Heterozygous

0.00008544

-

-

Thompson et al., 2005 [96]

chr14:67729258_67729266del

NM_152443.3: c.735_743del (p.Cys245_Leu247del)

Heterozygous

Absent

-

-

Ba-Abbad et al., 2020 [97]

F2

GE

Rod-cone dystrophy

Sporadic (AR)

NPHP4

chr1:5986310G>A

NM_015102.5: c.-21C>T

Heterozygous

0.00001972

uAUG gain: uORF out of frame and overlapping with CDS

Not available

Yes (if padded)

This study

chr1:5961845C>G

NM_015102.5: c.622G>C (p.Val208Leu)

Heterozygous

Absent

-

-

F3

GE

Macular dystrophy

Sporadic (AR)

NMNAT1

chr1:9943515G>A

NM_022787.4: c.-57G>A

Heterozygous

Absent

Splice donor site loss

Yes

No

This study

chr1:9982341G>C

NM_022787.4: c.480G>C (p.Leu160Phe)

Heterozygous

0.000006573

-

-

F4

GE

LCA or Early-Onset Severe Retinal Dystrophy

AD

PRPF31

chr19:54115798G>A

NM_015629.4: c.-9+1G>A

Heterozygous

Absent

Splice donor site loss/gain

Yes

No

Daich Varela et al., 2023 [49]

F5

GE

Rod-cone dystrophy

Sporadic (AD)

PRPF31

chr19:54115798G>T

NM_015629.4: c.-9+1G>T

Heterozygous

Absent

Splice donor site loss/gain

De novo

No

Liu et al., 2008 [98]

F6

GE

Familial exudative vitreoretinopathy

Sporadic (X-linked)

NDP

chrX:43958715C>T

NM_000266.4: c.-70G>A

Hemizygous

Absent

Splice donor site gain

Yes

Yes

Daich Varela et al., 2023 [49]

F7

GE

Rod-cone dystrophy

Sporadic (AR)

RD3

chr1:211492150C>T

NM_001164688.2: c.-394G>A

Homozygous

Absent

Change in secondary structure and/or retinal TSS

Yes

No

This study

F8

GE

LCA or Early-Onset Severe Retinal Dystrophy

Sporadic (AR)

MERTK

chr2:111898611G>A

NM_006343.3: c.-125G>A

Homozygous

0.00002632

Change in secondary structure and/or retinal TSS

Yes

Yes

This study

F9

GE

Cone Dysfunction Syndrome

AD

PAX6

chr11:31806455A>G

NM_001368894.2: c.-44T>C

Heterozygous

Absent

Change in secondary structure

Yes

Yes

This study

F10

CMGG

Retinal dystrophy with macular involvement

AR

ARL3

chr10:102714363C>T

NM_004311.4: c.-88G>A

Heterozygous

Absent

Change in secondary structure

Yes

Yes (if padded)

This study

F11

CMGG

Rod-cone dystrophy/BBS

Sporadic (AR)

PRPF4

chr9:113275738C>T

NM_001244926.2: c.-6C>T

Heterozygous

Absent

Alteration of primary Kozak consensus

Not available

Yes

This study

  1. AD autosomal dominant, AR autosomal recessive, BBS Bardet -Biedl syndrome, CMGG Center for Medical Genetics Ghent, GE Genomics England, LCA Leber congenital amaurosis, MAF minor allele frequency, TSS transcription start site, uORF upstream open reading frame.
  2. aThe status of this case in the GE Research Environment was classified as "solved" for RDH12-associated disease before this study
  3. bIn-house capture kits (SureSelect Human All Exon V6 and SureSelect Human All Exon V7)